Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Erythropoietin Stimulating Agents Market by Type (Darbepoetin Alfa, Epoetin Alfa, Epoetin Beta), Application (Anemia, Antiretroviral Treatment, Cancer Chemotherapy) - Global Forecast 2024-2030
... 2023 and expected to reach USD 10.32 billion in 2024, at a CAGR 5.64% to reach USD 14.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Erythropoietin Stimulating ... Read More
-
Anemia Drugs Market by Drug (Alglucerase Injection, Carbonyl Iron, Cyanocobalamin), Type (Aplastic Anemia, Chronic Kidney Disease Anemia, Hemolytic Anemia), Route of Administration, End-Users - Global Forecast 2024-2030
... USD 19.55 billion in 2023 and expected to reach USD 21.24 billion in 2024, at a CAGR 10.76% to reach USD 39.99 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Global Sickle Cell Anemia Therapeutics Market Research Report 2024(Status and Outlook)
... carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). The Global Sickle Cell ... Read More
-
Global Renal Anemia Therapeutics Market 2024-2028
... renal anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Immune Thrombocytopenia Drug Market (2024 Edition): Analysis By Treatment (Intravenous Immunoglobulins, Thrombopoietin Receptor Agonists, Corticosteroids, Others), By Type, By End-User, By Region: Market Insights and Forecast (2019-2029)
... research report titled “Global Immune Thrombocytopenia Drug Market (2024 Edition)” which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglobulins, Thrombopoietin Receptor Agonists, Corticosteroids, ... Read More
-
Global Plasma Fractionation Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Blood Disease Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Blood Disease Drugs Industry Forecasts - China Focus
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
Blood Disease Drugs Markets in China
... Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's ... Read More
-
Hemophilia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... by 2028, exhibiting a growth rate (CAGR) of 11.35% during 2022-2028. Hemophilia is an inherited medical disorder that affects the blood clotting process, wherein the blood clots abnormally. It results in spontaneous and excessive bleeding, ... Read More
-
Glucose Analysis Tubes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global revenue from the glucose analysis tubes market reached approximately US$ 480 million in 2024, with a projected CAGR of 5.5%. The market is expected to reach a valuation of approximately US$ 700 million ... Read More
-
Fanconi Anemia Drug Market, By Treatment Type (Hematopoietic Growth Factors, Gene Therapy, Stem Cell Transplantation, and Other Therapies), By Age Group (Pediatric Patients and Adult Patients), By Disease Stage (Early-stage Disease and Advanced-stage Disease), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) The fanconi anemia drugs are pharmaceutical therapies and treatments that have been created or are currently being researched with the goal of ... Read More
-
Global Chronic Immune Thrombocytopenia Market - 2023-2030
... the forecast period 2023-2030. Chronic Immune Thrombocytopenia (ITP) is an autoimmune bleeding disorder that occurs due to decreased platelet secretion, preventing blood clotting. An average platelet count ranges from approximately 150,000 to 400,000 per blood ... Read More
-
Bleeding Disorders Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 20.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028. Bleeding disorders involve hemophilia A and B, Von Willebrand disease, idiopathic thrombocytopenic purpura (ITP), and deficiencies of vitamin ... Read More
-
2023 Blood & AutoImmune Diseases Global Market Size & Growth Report with COVID-19 & Recession Risk Impact
... and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. The historical ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2023-2030
... 11.40 billion by 2030 from USD 3.83 billion in 2022, at a CAGR of 14.60% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends ... Read More
-
Bleeding Disorders Treatment Market by Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease), Drug Class (Antibrinolytics, Desmopressin, Fibrin Sealant), Distribution Channel - Global Forecast 2023-2030
... USD 25.25 billion by 2030 from USD 12.42 billion in 2022, at a CAGR of 9.27% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging ... Read More
-
Plasma Fractionation Market, 2023-2035
... ~10% during the forecast period. Over the past two decades, the number of patients affected with rare diseases have increased tremendously. In fact, over 410 million people are currently suffering from rare and chronic disorders. ... Read More
-
Global Alpha Thalassemia Market - 2023-2030
... forecast period 2023-2030. The alpha thalassemia market trends show rising research owing to the rising technological advancements. When one or more of the four alpha-globin genes—which are responsible for producing hemoglobin—are damaged or absent, alpha ... Read More
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
... size is projected to reach USD 40.4 billion by 2028 from USD 29.0 billion in 2023, at a CAGR of 6.9% during the forecast period. Expanding the number of plasma collection centers allows market players ... Read More
-
Plasma Fractionation Global Market Briefing 2023
... (CAGR) of 7.35%. The global plasma fractionation market is expected to grow from $26.39 billion in 2022 to $69.35 billion in 2032 at a CAGR of 10.14%. Plasma Fractionation Global Market Briefing 2023 provides strategists, ... Read More
-
2023 Blood & AutoImmune Diseases Global Market Size & Growth Report with Global Recession Risk Impact
... share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. The historical data ... Read More
-
Global Blood Plasma Market: Analysis By Demand, By Production Capacity, By Type, By Industry, By Application, By Region, Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028
... component of blood, plays a vital role in the field of medicine. Comprising proteins, hormones, electrolytes, and antibodies, it serves as a crucial resource for various therapeutic applications. Blood plasma holds significant medical importance due ... Read More
-
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032
... the 3MM, at an AGR of 0.61%. Currently, the treatment regimen for vWD in the 3MM is mostly limited to DDAVP and coagulation factor VIII + vWF complex. There are several unmet needs in this ... Read More
-
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030 Given ... Read More